USCWA
RVNC

U.S. Capital Wealth Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History

U.S. Capital Wealth Advisors’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-250
Closed -$4.62K – 1571
2022
Q4 		$4.62K Buy
+250
New +$4.62K ﹤0.01% 1400